Δ32 mutation frequencies of the CCR5 coreceptor in different French regions;Δ32 FREQUENCES DE LA MUTATION Δ32 DU GENE DU CORECEPTEUR CCR5 DANS LES DIFFERENTES REGIONS FRANCAISES

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 321, Issue 5, 1998, Pages 409-413

  Lucotte, Gérard ^a,b   Mercier, Géraldine ^a,b  

^a Inst International d'Anthropologie   (France)

^b HÔPITAL MAISON BLANCHE   (France)

Author keywords

Coreceptor CCR5; Disparity between the north and the south of the country; Frequency of the mutation in France; Resistance to HIV 1; 32 mutation

Indexed keywords

CHEMOKINE RECEPTOR; DNA; CHEMOKINE RECEPTOR CCR5;

ARTICLE; FRANCE; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RESISTANCE; MUTATION RATE; NORMAL HUMAN; POPULATION GENETICS; RECEPTOR GENE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; GENE FREQUENCY; GENETICS; HOMOZYGOTE; INNATE IMMUNITY; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DNA MUTATIONAL ANALYSIS; FRANCE; GENE FREQUENCY; HOMOZYGOTE; HUMANS; IMMUNITY, NATURAL; MUTATION; POLYMERASE CHAIN REACTION; RECEPTORS, CCR5;

EID: 0032077596     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(98)80305-3     Document Type: Article

References (18)

1. [1] Samson M., Libert F., Doranz B.J., Rucker J., Liesnard C., Farber C.M., Saragosti S. et al., Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene, Nature 382 (1996) 722-725.
2. [2] Liu R., Paxton W.A. Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E. et al., Homozygous defect in HIV-1 coreceptor accounts for resistance to some multiply-exposed individuals to HIV-1 infection, Cell 86 (1996) 367-377.
3. [3] Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets C., Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene, Science 273 (1996) 1856-1862.
4. [4] Huang Y., Paxton W.A., Wolinsky S.M., Neumann A.U., Zhang L., He T., Kang S., The role of a mutant CCR5 allele in HIV-1 transmission and disease progression, Nat. Med. 2 (1996) 1240-1243.
5. [5] Michael N.L., Chang G., Louie L.G., Mascola J.R., Dondero D., Birx D.L., Sheppard H.W., The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat. Med. 3 (1997) 338-340.
6. [6] Biti R., Ffrench R., Young J., Bennetts B., Stewart G., HIV-1 infection in an individual homozygous for the CCR5 deletion allele, Nat. Med. 3 (1997) 252-253.
7. [7] O'Brien T.R., Winkler C., Dean M., Nelson J.A.E., Carrington M., Michael N.L., White II G.C., HIV-1 infection in a man homozygous for CCR5 32, Lancet 349 (1997) 1219.
8. [8] Theodorou I., Meyer L., Magierowska M., Katlama C., Rouzioux C., SEROCO Study Group, HIV-1 infection in an individual homozygous for CCR5 32, Lancet 349 (1997) 1219-1220.
9. [9] Zimmerman P.A., Buckler-White A., Alkhatib G., Spalding T., Kubofcik J., Combadière C., Weissman D. et al., Inherited resistance to HIV-1 confered by an inactivating mutation in the CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk, Mol. Med. 3 (1997) 23-36.
10. [10] Martinson J.J., Chapman N.H., Rees D., Liu Y.T., Glegg J.B., Global distribution of the CCR5 gene Δ32-basepair deletion, Nat. Genet. 16 (1997) 100-103.
11. [11] Gautreau C., Rahuel C., Cartron J.P., Lucotte G., Comparison of two methods of high-molecular-weight DNA isolation from human leucocytes, Anal. Biochem. 134 (1983) 320-324.
12. [12] Rahuel C., Dandieu S., Chaussé A.M., Mornet E., Rouger P., Cartron J.P., Salmon C., Lucotte G., Constitution d'une banque d'ADN d'origine humaine, Rev. Franç. Transf. Immuno-Hématol. 26 (1983) 539-552.
13. [13] Lucotte G., Turpin J.C., Raisonnier A., Association of apolipoprotein E4 allele with late and early Alzheimer's disease, but not with vascular dementia or Parkinson's disease in French patients, Alzh. Dis. 1 (1995) 145-146.
14. [14] Lucotte G., Gradient de valeurs décroissantes selon l'axe nordouest/sud-est dans la distribution géographique de la mutation principale de la mucoviscidose en France, Arch. Fr. Pédiatr. 49 (1992) 753-754.
15. [15] Lucotte G., Mazout S., Y-chromosome DNA haplotypes in Basques, J. Mol. Evol. 42 (1996) 472-475.
16. [16] Lucotte G., Frequencies of the CC chemokine receptor 5 Δ32 allele in various populations of defined racial background, Biomed. & Pharmacother. 51 (1997) 469-473.
17. [17] Lucotte G., Hazout S., Loirat F., North-west/south-east gradient in F508 frequency in Europe, Lancet 338 (1991) 882-883.
18. [18] Loirat F., Lucotte G., Fréquences de la mutation principale (F508) de la mucoviscidose en France: résultats sur 2 617 familles dans l'ensemble des régions, Arch. Pédiatr. 4 (1997) 687-689.